Tech Company Financing Transactions
Ossium Health Funding Round
On 3/22/2021, Ossium Health announced $63 million in Series B financing from General Catalyst Partners, Vivo Capital and First Round Capital.
Transaction Overview
Company Name
Announced On
3/22/2021
Transaction Type
Venture Equity
Amount
$63,000,000
Round
Series B
Investors
General Catalyst Partners (Lead Investor)
Vivo Capital (Lead Investor)
Proceeds Purpose
The funds will support an initial suite of clinical trials to use donor-matched hematopoietic stem cells to re-educate the immune systems of organ recipients to accept donor organs, to deploy the anti-inflammatory properties of mesenchymal stem cells to promote healing in patients with fistulizing Crohn's disease, and to reset the malignant immune systems of hard to match blood cancer patients using bone marrow transplants from organ donors.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
5742 W 74th St.
Indianapolis, IN 46278
USA
Indianapolis, IN 46278
USA
Phone
Website
Email Address
Overview
Ossium's mission is to improve human health. We will deploy cellular therapeutics, bioengineering, and other regenerative medical tools to produce lasting gains in the health, vitality, and longevity of human beings. In pursuit of these goals, we will foster a culture that empowers our stakeholders, maintain the highest standards of operational excellence.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Kevin Caldwell
Chief Medical Officer
Scott Goebel
Chief Scientific Officer
Erik Woods
VP - Human Resources
Jay Gardner
VP - Operations
Margie Mathewson
VP - R & D
Brian Johnstone
VP - Regulatory Affairs
Oliver Cacananta
VP - Regulatory Affairs
Jonathon Rochelle
Browse more venture capital transactions:
Prev: 3/22/2021: Act-On Software venture capital transaction
Next: 3/23/2021: DexCare venture capital transaction
Share this article
Where The Data Comes From
We do our best to record every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs